chimeric antigen receptor t cells

Accelerating The Path To Cell Therapy Commercialization

With its modular design and flexibility, Thermo Fisher Scientific’s innovative GibcoTM CTSTM Rotea Counterflow Centrifugation System enables the scalable and cost-effective commercialization of cell therapies.

From Beer To Bispecifics And Beyond

Kiran Mazumdar-Shaw, chairman and managing director of Biocon, shares her thoughts on Asia’s growing role in biotech R&D.

CAR-T Therapy Shows Promising Results Against Myeloma

Innovent Biologics' CT103A, a promising therapy for tough-to-treat blood cancer, has shown positive results in clinical trials.

JW Therapeutics Raises US$90 Million In Series A Funding Round

The funds will be used to further advance JW Therapeutic's chimeric antigen receptor T-cell clinical program, develop a therapeutic pipeline and build a new commercial manufacturing facility.

Immunotherapy Homes In On Multiple Myeloma

Scientists in Japan have identified a monoclonal antibody that can be used in CAR-T therapy against multiple myeloma.

When T Spells Trouble For Cancer

The world’s largest clinical trial of T-cells for cancer is being conducted by a Singapore-based biotech company, Tessa Therapeutics. Sim Shuzhen finds out more.

Takeda And Noile-Immune Biotech Enter CAR-T Collaboration

Takeda and Noile-Immune Biotech collaborate to advance next generation CAR-T therapy effective for solid tumors.

[INFOGRAPHIC] What You Need To Know About Immunotherapy

Our immune system protects us against a host of infections, but it can also be trained to seek out and destroy cancer.

CBMG & GE Healthcare Life Sciences Collaborate On Cancer Immunotherapy

CMBG and GE Healthcare Life Sciences China have entered a strategic colllaboration to develop industrial control processes in CAR-T and stem cell manufacturing.

Genetically Engineered Killer T-Cells That Seek Out Brain Tumors

Researchers have engineered CAR T-cells to specifically identify and destroy brain tumors in mouse models.